Jake Pond
Director
Jake is a strategic and experienced public affairs specialist with a unique expertise in guiding clients through complex and commercially sensitive policy challenges.
Working at the interface of life sciences strategy and medicines access, Jake has been a key contributor to meaningful health policy change – leading successful programmes and campaigns that have helped positively shape the medicines landscape in the UK and across Europe.
With extensive knowledge of HTA processes, Jake has supported biotech and pharmaceutical clients across a broad spectrum of medicine appraisals spanning multiple therapy areas and technology types. His work includes significant experience in rare diseases and advanced therapy medicinal products (ATMPs), where he has advised on highly innovative treatments facing increasingly unique access hurdles.
Jake is passionate about driving positive policy change that prioritises collaboration and partnership, with a firm focus on ensuring patients can access new treatments and innovations as swiftly as possible.